Fluorocarbon emulsions as in vivo oxygen delivery systems. Background and chemistry

Blood Substitutes

Volumn , Issue , 2006, Pages 259-275

  Riess, Jean G ^a   Krafft, Marie Pierre ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INSTITUT CHARLES SADRON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882458456     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012759760-7/50033-0     Document Type: Chapter

References (54)

1. Audonnet-Blaise S., Krafft M.P., Smani Y., et al. Improved tissue oxygenation in rabbits subjected to a hemorrhagic shock restored with a new generation perfluorocarbon emulsion. Shock 2004, in press.
2. Cabrales P., Tsai A.G., Frangos J.A., et al. Oxygen delivery and consumption in the microcirculation after extreme hemodilution with perfluorocarbons. Am. J. Physiol. Heart Circ. Physiol. 2004, 287:H320-H330.
3. Clark L.C., Gollan F. Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science 1966, 152:1755-1756.
4. Correas J.-M., Meuter A.R., Singlas E., et al. Human pharmacokinetics of a perfluorocarbon ultrasound contrast agent evaluated with gas chromatography. Ultrasound Med. Biol. 2001, 27:565-570.
5. Costa-Gomez M.F., Deschamps J., Menz D.-H. Solubility of dioxygen in seven fluorinated liquids. J. Flurorine Chem. 2004, 125:1325-1329.
6. Daugherty W.P., Levasseur J.E., Sun D., et al. Perfluorocarbon emulsion improves cerebral oxygenation and mitochondrial function after fluid percussion brain injury in rats. Neurosurgery 2004, 54:1223-1230.
7. DeRoover A., Krafft M.P., Deby-Dupont G., et al. Seventy-two hour hypothermic intestinal preservation study using a new perfluorocarbon emulsion. Artif. Cells Blood Subst. Immob. Biotech. 2001, 29:225-234.
8. Dromsky D.M., Spiess B.D., Fahlman A. Treatment of decompression sickness in swine with intravenous perfluorocarbon emulsion. Aviat. Space Environ. Med. 2004, 75:301-305.
9. Eckman D.M., Lomivorotov V.N. Microvascular gas embolization clearance following perfluorocarbon administration. J. Appl. Physiol. 2003, 94:860-868.
10. Ellena J.F., Obraztsov V.V., Cumbea V.L., et al. Perfluorooctyl bromide has limited membrane solubility and is located at the bilayer center. Locating small molecules in lipid bilayers through paramagnetic enhancements of NMR relaxation. J. Med. Chem. 2002, 45:5534-5542.
11. Faithfull N.S. The concept of hemoglobin equivalency of perfluorochemical emulsions. Adv. Exp. Med. Biol. 2003, 530:271-285.
12. Fan X., River J.N., Zamora M., et al. Effect of carbogen on tumor oxygenation: combined fluorine-19 and proton MRI measu rements. Intl. J. Rad. Oncol. Biol. Phys. 2002, 54:1202-1209.
13. Frumento R.J., Mongero L., Naka Y., Bennett-Guerrero E. Preserved gastric tonometric variables in cardiac surgical patients administered intravenous perflubron emulsion. Anesth. Analg. 2002, 94:809-814.
14. Gessler A.E., Bender C.E., Parkinson M.C. A new and rapid method for isolating viruses by selective fluorocarbon deproteinization. Trans. NY Acad. Sci. 1956, 18:701-703.
15. Geyer R.P., Monroe R.G., Taylor K. Survival of rats totally perfused with a fluorocarbon-detergent preparation. Organ Perfusion and Preservation 1968, 85-96. Appleton-Century-Crofts, New York. J.C. Norman (Ed.).
16. Gjadlbaek J., Hildebrand J.H. The solubility of nitrogen in carbon disulfide, benzene, normal-and cyclo-hexane, and in three fluorocarbons. J. Am. Chem. Soc. 1949, 71:3147-3150.
17. Herren J.I., Kunzelman K.S., Vocelka C., et al. Angiographic and histological evaluation of porcine retinal vascular damage and protection with perfluorocarbons after massive air embolism. Stroke 1998, 29:2396-2403.
18. Howlett S., Dundas D., Sabiston D.C. Fluid fluorocarbon as oxygenator in experimental extracorporeal circulation. Arch. Surg. 1965, 91:643-645.
19. Hsu Y.-C., Peng C.-A. Diminution of phagocytosed perfluorocarbon emulsions using perfluoroalky lated polyethy lene glycol surfactant. Biochem. Biophys. Res. Commun. 2001, 283:776-781.
20. Isaka M., Imamura M., Makino Y., et al. Abstracts, International Symposium on Blood Substitutes 2003.
21. Ivanitsky G.R. Biophysics at the turn of the millenium: perfluorocarbon media and gas-transporting blood substitutes. Biophysics 2001, 46:1-31. (translated from Biofizika).
22. Kaufman R.J. Clinical development of perfluorocarbon-based emulsions as red cell substitutes. Blood Substitutes: Physiological Basis of Efficacy 1995, 53-75. Birkhäuser, Boston. R.M. Winslow, K.D. Vandegriff, M. Intaglietta (Eds.).
23. Kaul D.K., Liu X., Nagel R.L. Ameliorating effects of fluorocarbon emulsion on sickle red blood cell-induced obstruction in an ex vivo vasculature. Blood 2001, 98:3128-3131.
24. Koch C.J., Oprysko P.R., Shuman A.L., et al. Radiosensitization of hypoxic tumor cells by dodecafluoropentane: a gas-phase perfluorochemical emulsion. Cancer Res. 2002, 62:3626-3629.
25. Kopac M.J. Recent developments in cellular micrurgy. Trans. NY Acad. Sci. 1955, 17:257-265.
26. Krafft M.P., Riess J.G., Weers J.G. The design and engineering of oxygen-delivering fluorocarbon emulsions. Submicronic Emulsions in Drug Targeting and Delivery 1998, 235-333. Harwood Academic, Amsterdam. S. Benita (Ed.).
27. Krafft M.P., Chittofrati A., Riess J.G. Emulsions and micro emulsions with a fluorocarbon phase. Curr. Opin. Colloid Interf. Sci. 2003, 8:251-258.
28. Krafft M.P., Marie Bertilla S., Marie P. Fluorocarbon-hydrocarbon diblocks as stabilizers of fluorocarbon emulsions. Keio University Int. Symp. for Life Siences and Medicine 2004, 12:237-251.
29. Lanza G.M., Wickline S.A. Targeted ultrasonic contrast agents for molecular imaging and therapy. Progr. Cardiovasc. Dis. 2001, 44:13-31.
30. Lanza G.M., Yu X., Winter P.M., et al. Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: implications for rational therapy of restenosis. Circulation 2002, 106:2842-2847.
31. Lebeau P., Damien A. Sur le tétrafluorure de carbone. C. R. Acad. Sci. Fr. 1926, 182:1340-1342.
32. Lowe K.C. Perfluorochemical respiratory gas carriers: benefits to cell culture systems. J. Fluorine Chem. 2002, 118:19-26.
33. Lundgren C.E., Bergoe G.W., Tyssebotn I. The theory and application of intravascular microbubbles as an ultra-effective means of transporting oxygen and other gases. Undersea Hyperb. Med. 2004, 31:105-106.
34. Marie Bertilla S., Thomas J.-L., Marie P., Krafft M.P. Co-surfactant effect of a semifluorinated alkane at a fluorocarbon/water interface. Impact on the stabilization of fluorocarbon-in-water emulsions. Langmuir 2004, 20:3920-3924.
35. Marsh J.N., Hall C.S., Scott M.J., et al. Improvements in the ultrasonic contrast of targeted perfluorocarbon nanoparticles using an acoustic transmission line model. IEEE Trans. Ultrasonics Ferroelectrics Frequency Control 2002, 49:29-38.
36. Mathurin J.-G., de Ceaurriz J., Audran M., Krafft M.P. Detection of perfluorocarbons in blood by headspace solid-phase microextraction combined with gas chromatography/mass spectrometry. Biomed. Chromatogr. 2001, 15:443-451.
37. Nomura Y., Fujii F., Sato C., et al. Exchange transfusion with fluorocarbon for studying synaptically evoked optical signal in rat cortex. Brain Res. Protoc. 2000, 5:10-15.
38. Noveck R.J., Shannon E.J., Leese P.T., et al. Randomized safety studies of intravenous perflubron emulsion II. Effects on immune function in healthy volunteers. Anesth. Analg. 2000, 91:812-822.
39. Paxian M., Rensing H., Geckeis K., et al. Perflubron emulsion in prolonged hemorrhagic shock. Anesthesiology 2003, 98:1391-1399.
40. Riess J.G., Cornélus C., Follana R., et al. Novel fluorocarbon-based injectable oxygen-carrying formulations with long-term roomtemperature storage stability. Adv. Exp. Med. Biol. 1994, 345:227-234.
41. Riess J.G. Injectable oxygen carriers (blood substitutes - raison d'être, chemistry, and some physiology. Chem. Rev. 2001, 101:2797-2920.
42. Riess J.G. Fluorous micro-and nanophases with a biomedical perspective. Tetrahedron 2002, 58:4113-4131.
43. Riess J.G. Fluorocarbon-based injectable gaseous microbubbles for diagnosis and therapy. Curr. Opin. Colloid Interf. Sci. 2003, 8:259-266.
44. Riess J.G. Fluorous materials for biomedical uses. Handbook of Fluorous Chemistry 2004, 521-573. Wiley-VCH, Weinheim. J.A. Gladysz, D.P. Curran, I. Horváth (Eds.).
45. Riess J.G. Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery. Artif. Cells Blood Subst. Immob. Biotech. 2005, 31:47-63.
46. Schutt E.S., Klein D.H., Mattrey R.M., Riess J.G. Injectable microbubbles as contrast agents for diagnostic ultrasound imaging: the key role of perfluorochemicals. Angew. Chem. Intl Ed. 2003, 42:3218-3235.
47. Shchukin E.D., Amelina E.A., Parfenova A.M. Influence of the nature of non-polar phase on the mechanical stability of adsorption layers of hydrocarbon and fluorocarbon surfactants at the interface between their acqueous solutions and nonpolar media. Colloids Surf. 2001, 176:35-51.
48. Simons J.H. The electrochemical process for the production of fluorocarbons. J. Electrochem. Soc. 1949, 95:47-67.
49. Sloviter H.A., Kamimoto T. Erythrocyte substitute for perfusion of brain. Nature 1967, 216:458-460.
50. Spahn D.R., Waschke K.F., Standl T., et al. Use of perflubron emulsion to decrease allogeneic blood transfusion in high-blood-loss non-cardiac surgery: results of a European Phase 3 study. Anesthesiology 2002, 97:1338-1349.
51. Unger E.C., Porter T., Culp W., et al. Therapeutic applications of lipid-coated microbubles. Adv. Drug Deliv. Rev. 2004, 56:1291-1314.
52. van Liew H.D., Burkard M.E. High oxygen partial pressure in tissue delivered by stabilized microbubbles. Adv. Exp. Med. Biol. 1997, 411:395-401.
53. Weers J.G., Liu J., Fields T., et al. Room temperature stable perfluorocarbon emulsions with acceptable half-lives in the reticuloendothelial system. Artif. Cells Blood Subst. Immob. Biotech. 1994, 22:1175-1182.
54. Weers J.G., Arlauskas R.A., Tarara T.E., Pelura T.J. Characterization of fluorocarbon-in-water emulsions with added triglyceride. Langmuir 2004, 20:7430-7435.